| GILEAD SCIENCES DL-,001 |
| USA |
| Gesundheit |
| US3755581036 / 885823 |
| GIS (Frankfurt) / GILD (NASDAQ) |
| FRA:GIS, ETR:GIS, GIS:GR, NASDAQ:GILD |
| https://www.gilead.com/ |
|
Gilead Sciences Inc. is a biopharmaceutical compan..
>Volltext.. |
| 130205.73 Mio. EUR |
| 143565.19 Mio. EUR |
| 24747.45 Mio. EUR |
| 12012.57 Mio. EUR |
| 6907.89 Mio. EUR |
| 5.55 EUR |
| 21244.1 Mio. EUR |
| 6243.51 Mio. EUR |
| 8234.1 Mio. EUR |
| 0.75 |
| -2.49% |
| 6007.23% |
| 2.03 EUR |
| 2.55% |
| 2.56% |
| 15.09.25 - 0.67782€ 13.06.25 - 0.67782€ >weitere anzeigen... |
| GILEAD, REMDESIVIR |
| 16.12.25 |
|